DrugsControl Media Services

News Detail

Drug panel may review Gennova's mRNA Omicron booster vaccine (18-04-2023)

New Delhi, 18 April 2023: The subject experts committee (SEC) under the drug regulatory authority is likely to review India's first mRNA-based Omicron specific Covid-19 booster shot for authorisation this week, people in the know told ET.

Pune-based Gennova Biopharmace......
View Details

Source : Economic Times
Gennova Biopharmaceuticals covid vaccine booster dose coronaviurs gennova mrna vaccine GEMCOVAC®-OM

Related News